In this work, we used WES based on cfDNA liquid biopsy for 55 lung and colorectal cancer patients to identify novel somatic variants associated with drug resistance after treatment including cytotoxic chemotherapy or EGFR targeted therapy. This evidence concerns the gene EGFR and colorectal cancer.